Skip to main content


Allergy Connect™ Education & Support Program

Allergy Connect Logo

We are delighted to introduce Allergy Connect™, an Allergy & Anaphylaxis Australia (A&AA) education and support program. This program is a significant leap forward in our vision to support individuals with allergies, and we’re starting with eczema! The Allergy Connect™ Education and Support (ACES) study - an Allergy Connect Program™ focussing on eczema, is currently a research collaboration between Allergy & Anaphylaxis Australia (A&AA) and Perth's Children’s Hospital.

What is Allergy Connect?

"Allergy Connect™" is an online education program designed to use the time gap between referral and specialist appointment for individuals dealing with allergies by empowering them with an education program to manage their allergic condition. It uses the latest digital technology to bring evidence-based information to the patient and is a collaboration, bringing together health professionals including specialists, allergy educators, and, most importantly, people living with allergies.

How Will It Help People with Allergies?

The core goal of "Allergy Connect™" is to empower patients with the knowledge they need to manage their allergic disease effectively while waiting for their clinical immunologist/allergist, other specialist, or healthcare professional appointment. This education will allow individuals to make informed decisions about managing their allergies. "Allergy Connect™" directs people to helpful information and offers hope to those navigating the often-challenging world of allergies, including eczema.

How We Are Progressing - Trial Phase

At present, the Allergy Connect™ Education and Support (ACES) study is focussing on eczema and is in its research trial phase. During this stage, we are collaborating with experts, patients, and healthcare providers to fine-tune the program's features and assess its functionality. Our goal is to make "Allergy Connect™" a user-friendly, comprehensive resource for individuals with allergies. We hope that once we have collected research about eczema, we can broaden the study to include food allergies, allergic rhinitis, and other allergic conditions.

What Can People Do Now?

While "Allergy Connect™" is in the trial phase, you can take proactive steps:

  • Register Your Interest: As the current ACES study focussing on eczema is a randomly controlled trial (RCT), you cannot register to be part of eczema program. However, if you're enthusiastic about the potential of "Allergy Connect™" and want to keep up to date as the program unfolds, please subscribe to Allergy & Anaphylaxis Australia.
  • Stay Informed: You can also subscribe to A&AA and keep an eye on our website and social media channels for regular updates on all our research, resources, and programs.
  • Contact Us for More Information: We recognize allergies can be complex, and you may have questions. Our dedicated team of Allergy Educators is here to provide answers and support. Reach out to us with your enquiries.
  • Make a donation – to support people on waiting lists with information and support from a credible and evidence-based source.

"Allergy Connect™" is not just a future vision; it's a tangible commitment to our allergy community. We invite you to subscribe as we step forward on this transformative journey, working together to improve the lives of people with allergies.


If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.